IDEXX Laboratories, Inc. (NasdaqGS:IDXX) Momentum in Focus as Slope Reading Stands at 58.53658

When looking to find solid stocks with smooth upward momentum, investors can take a look at the 125/250 day adjusted slope indicator.  At the time of writing IDEXX Laboratories, Inc. (NasdaqGS:IDXX) have a current value of 58.53658.  The point of this calculation is to calculate a longer term average adjusted slope value that smooths out large stock price movements by using the average of the timeframe. This indicator is useful in helping find stocks that have been on an even upward trend over the past 6 months to a year. 

With so many different stock trading strategies to choose from, new investors may become overwhelmed when presented with all the possible options. Some investors will choose to rely on the expertise of professionals, while others will try to have a go at it on their own. Investors who prefer to do their own research and make their own investment decisions are quite common these days. Of course there is no set in stone way to properly trade the stock market. Markets and economic situations are constantly changing. Staying on top of all the latest information and global developments can be challenging. Investors who are able to stay the course and put in the required time might be able to eventually give themselves a leg up in the future.

IDEXX Laboratories, Inc. (NasdaqGS:IDXX) of the Health Care Equipment & Services sector closed the recent session at 268.710000 with a market value of $23133265.

Investor Target Weight

IDEXX Laboratories, Inc. (NasdaqGS:IDXX) has a current suggested portfolio rate of 0.04870 (as a decimal) ownership.  Target weight is the volatility adjusted recommended position size for a stock in your portfolio.  The maximum target weight is 7% for any given stock.  The indicator is based off of the 100 day volatility reading and calculates a target weight accordingly.  The more recent volatility of a stock, the lower the target weight will be.  The 3-month volatility stands at 22.841100 (decimal).  This is the normal returns and standard deviation of the stock price over three months annualized. 

Drilling down into some additional key near-term indicators we note that the Capex to PPE ratio stands at 0.247238 for IDEXX Laboratories, Inc. (NasdaqGS:IDXX).  The Capex to PPE ratio shows you how capital intensive a company is. Stocks with an increasing (year over year) ratio may be moving to be more capital intensive and often underperform the market. Higher Capex also often means lower Free Cash Flow (Operating cash flow – Capex) generation and lower dividends as companies don’t have the cash to pay dividends if they are investing more in the business.

When the stock market is doing well, there may be plenty of winners in the portfolio. Figuring out when to sell a winner can be a tricky proposition. Many investors will be quick to take profits while others may want to hold out for further gains. Selling winners too early or holding on to winners too long may have a negative impact on the trading portfolio. Finding that balance between securing profits and holding out to take higher profits in the future can be very helpful for the active investor. 

In addition to Capex to PPE we can look at Cash Flow to Capex.  This ration compares a stock’s operating cash flow to its capital expenditure and can identify if a firm can generate enough cash to meet investment needs.  Investors are looking for a ratio greater than one, which indicates that the firm can meet that need. Comparing to other firms in the same industry is relevant for this ratio. IDEXX Laboratories, Inc. (NasdaqGS:IDXX)’s Cash Flow to Capex stands at 3.064190.

Debt

In looking at some Debt ratios, IDEXX Laboratories, Inc. (NasdaqGS:IDXX) has a debt to equity ratio of 6.05219 and a Free Cash Flow to Debt ratio of 0.271585.  This ratio provides insight as to how high the firm’s total debt is compared to its free cash flow generated.  In terms of Net Debt to EBIT, that ratio stands at 1.73738.  This ratio reveals how easily a company is able to pay interest and capital on its net outstanding debt.  The lower the ratio the better as that indicates that the company is able to meet its interest and capital payments. Lastly we’ll take note of the Net Debt to Market Value ratio.  IDEXX Laboratories, Inc.’s ND to MV current stands at 0.040010. This ratio is calculated as follows: Net debt (Total debt minus Cash ) / Market value of the company.

Investors may be looking closely at current stock market levels as we move towards the closing stages of the year. Investors might be reviewing current holdings to see if there are any changes that need to be made. Even when things are going good with equities, it may be wise to regularly check the portfolio to make sure that everything is still balanced properly. Being prepared for various market conditions may be a great help to the investor when the winds of change eventually blow in.    

Near-Term Growth Drilldown

Now we’ll take a look at some key growth data as decimals. One year cash flow growth ratio is calculated on a trailing 12 months basis and is a one year percentage growth of a firm’s cash flow from operations.  This number stands at 0.06013 for IDEXX Laboratories, Inc. (NasdaqGS:IDXX).  The one year Growth EBIT ratio stands at 0.18493 and is a calculation of one year growth in earnings before interest and taxes.  The one year EBITDA growth number stands at 0.15414 which is calculated similarly to EBIT Growth with just the addition of amortization.

Taking even a further look we note that the 1 year Free Cash Flow (FCF) Growth is at 0.17377.  The one year growth in Net Profit after Tax is 0.37621 and lastly sales growth was 0.10121.

Traders may already have a favorite method for applying technical analysis. Active traders are typically concerned with shorter-term price movements when trading shares. Entry and exit points tend to be way more important for traders who are looking to capitalize on stock market trends. Some traders may opt to only use technical analysis when picking stocks, while others will also incorporate company fundamentals when doing research. Of course, there is no one foolproof method for trading the markets. Many technical investors will still opt to familiarize themselves with the fundamentals before diving deeper into the technical signals. Longer-term investors might not be as concerned with day to day price fluctuations while short-term traders may not want to miss out on any significant price swings. Whatever trading strategy is applied, investors may still want to try to get a sense of the overall picture before making the trade.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Comment

Your email address will not be published. Required fields are marked *